Evolva Holding SA (EVE.SW)
CHF 0.84
(-6.44%)
CHF 0.84
(-6.44%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -19.50 CHF | -38.6% |
| 2022 | -10.13 CHF | 13.57% |
| 2021 | -11.72 CHF | -23.5% |
| 2020 | -9.49 CHF | -35.19% |
| 2019 | -7.02 CHF | 25.95% |
| 2018 | -9.48 CHF | 53.09% |
| 2017 | -20.21 CHF | 10.46% |
| 2016 | -22.57 CHF | 0.04% |
| 2015 | -22.58 CHF | -16.33% |
| 2014 | -19.41 CHF | -12.26% |
| 2013 | -17.29 CHF | 5.67% |
| 2012 | -18.33 CHF | 35.32% |
| 2011 | -28.34 CHF | 14.1% |
| 2010 | -32.99 CHF | -16.57% |
| 2009 | -28.30 CHF | 95.21% |
| 2008 | -590.63 CHF | 4.14% |
| 2007 | -616.12 CHF | 28.3% |
| 2006 | -859.34 CHF | -80.88% |
| 2005 | -475.08 CHF | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.19 CHF | 0.0% |
| 2023 Q2 | -17.60 CHF | 0.0% |
| 2023 Q4 | -2.18 CHF | 0.0% |
| 2023 FY | - CHF | -38.6% |
| 2022 Q2 | -6.55 CHF | 0.0% |
| 2022 Q4 | -3.25 CHF | 0.0% |
| 2022 FY | - CHF | 13.57% |
| 2021 FY | - CHF | -23.5% |
| 2021 Q4 | -4.21 CHF | 0.0% |
| 2021 Q2 | -7.52 CHF | 0.0% |
| 2020 FY | - CHF | -35.19% |
| 2020 Q2 | -4.34 CHF | 0.0% |
| 2020 Q4 | -5.15 CHF | 0.0% |
| 2019 FY | - CHF | 25.95% |
| 2019 Q2 | -3.33 CHF | 0.0% |
| 2019 Q4 | -3.65 CHF | 0.0% |
| 2018 FY | - CHF | 53.09% |
| 2018 Q2 | -5.00 CHF | 0.0% |
| 2018 Q4 | -4.50 CHF | 0.0% |
| 2017 Q2 | -12.50 CHF | 0.0% |
| 2017 FY | - CHF | 10.46% |
| 2017 Q4 | -8.36 CHF | 0.0% |
| 2016 FY | - CHF | 0.04% |
| 2016 Q2 | -12.50 CHF | 0.0% |
| 2016 Q4 | -10.20 CHF | 0.0% |
| 2015 FY | - CHF | -16.33% |
| 2015 Q4 | -10.16 CHF | 0.0% |
| 2015 Q2 | -12.50 CHF | 0.0% |
| 2014 Q4 | -9.44 CHF | 0.0% |
| 2014 FY | - CHF | -12.26% |
| 2014 Q2 | -10.00 CHF | 0.0% |
| 2013 Q4 | -10.49 CHF | 0.0% |
| 2013 FY | - CHF | 5.67% |
| 2013 Q2 | -7.50 CHF | 0.0% |
| 2012 FY | - CHF | 35.32% |
| 2012 Q4 | -0.01 CHF | 26.32% |
| 2012 Q1 | -0.02 CHF | 0.0% |
| 2012 Q2 | -0.02 CHF | 0.0% |
| 2012 Q3 | -0.02 CHF | 0.0% |
| 2011 Q1 | -0.03 CHF | 0.0% |
| 2011 Q2 | -0.03 CHF | 0.0% |
| 2011 Q3 | -0.03 CHF | 0.0% |
| 2011 Q4 | -0.02 CHF | 32.62% |
| 2011 FY | - CHF | 14.1% |
| 2010 FY | - CHF | -16.57% |
| 2010 Q4 | -0.03 CHF | 14.55% |
| 2010 Q3 | -0.03 CHF | 0.0% |
| 2010 Q2 | -0.03 CHF | 0.0% |
| 2010 Q1 | -0.03 CHF | 0.0% |
| 2009 Q2 | -0.03 CHF | 0.0% |
| 2009 Q4 | -0.03 CHF | -16.61% |
| 2009 Q3 | -0.03 CHF | 0.0% |
| 2009 FY | - CHF | 95.21% |
| 2009 Q1 | -0.03 CHF | 0.0% |
| 2008 Q1 | -0.63 CHF | 0.0% |
| 2008 Q4 | -0.03 CHF | 95.51% |
| 2008 Q3 | -0.63 CHF | 0.0% |
| 2008 FY | - CHF | 4.14% |
| 2008 Q2 | -0.63 CHF | 0.0% |
| 2007 Q3 | -0.62 CHF | 0.0% |
| 2007 Q1 | -0.62 CHF | 0.0% |
| 2007 Q4 | -0.63 CHF | -1.61% |
| 2007 FY | - CHF | 28.3% |
| 2007 Q2 | -0.62 CHF | 0.0% |
| 2006 Q3 | -0.86 CHF | 0.0% |
| 2006 Q2 | -0.86 CHF | 0.0% |
| 2006 Q1 | -0.86 CHF | 0.0% |
| 2006 FY | - CHF | -80.88% |
| 2006 Q4 | -0.62 CHF | 27.91% |
| 2005 FY | - CHF | 0.0% |
| 2005 Q4 | -0.86 CHF | -79.17% |
| 2005 Q3 | -0.48 CHF | 0.0% |
| 2005 Q2 | -0.48 CHF | 0.0% |
| 2005 Q1 | -0.48 CHF | 0.0% |
| 2004 Q4 | -0.48 CHF | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Addex Therapeutics Ltd | -0.14 CHF | -13828.571% |
| BB Biotech AG | -3.77 CHF | -417.241% |
| Basilea Pharmaceutica AG | 0.87 CHF | 2341.379% |
| Idorsia Ltd | -1.67 CHF | -1067.665% |
| Kuros Biosciences AG | -0.38 CHF | -5031.579% |
| Molecular Partners AG | -1.89 CHF | -931.746% |
| Relief Therapeutics Holding AG | -8.35 CHF | -133.533% |
| Santhera Pharmaceuticals Holding AG | 5.18 CHF | 476.448% |